Cryptogenic Stroke and High-Risk Patent Foramen OvalePil Hyung Lee, Seung‐Jung Park, Sahmin Lee et al.|Journal of the American College of Cardiology|2018Cited by 570
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 InfectionJin Yong Kim, Kim Ys, Young Rock Jang et al.|Clinical Therapeutics|2021Cited by 47